ETMR: a tumor entity in its infancy Sander LamboKatja von HoffMarcel Kool Review Open access 29 June 2020 Pages: 249 - 266
Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline Juan Lantero RodriguezThomas K. KarikariNicholas J. Ashton Original Paper Open access 27 July 2020 Pages: 267 - 278
Reduction of advanced tau-mediated memory deficits by the MAP kinase p38γ Arne IttnerPrita Riana AsihLars M. Ittner Original Paper 29 July 2020 Pages: 279 - 294
miR155 regulation of behavior, neuropathology, and cortical transcriptomics in Alzheimer's disease Ben ReadheadJean-Vianney Haure-MirandeMichelle E. Ehrlich Original Paper 14 July 2020 Pages: 295 - 315
SFPQ and Tau: critical factors contributing to rapid progression of Alzheimer’s disease Neelam YounasSaima ZafarInga Zerr Original Paper Open access 23 June 2020 Pages: 317 - 339
Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease S. Bandres-CigaS. Saez-Atienzarthe International Parkinson Disease Genomics Consortium Original Paper Open access 29 June 2020 Pages: 341 - 358
Lesion stage-dependent causes for impaired remyelination in MS Katharina HeßLaura StarostTanja Kuhlmann Original Paper Open access 24 July 2020 Pages: 359 - 375
The KBTBD6/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatment Yan Ting LiuFang LiuZhe Bao Wu Original Paper 22 June 2020 Pages: 377 - 396
Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19 Zane JaunmuktaneUla MahadevaSebastian Brandner Correspondence Open access 08 July 2020 Pages: 397 - 400
ATP10B and the risk for Parkinson’s disease Raquel RealAnni Moorethe International Parkinson’s Disease Genomics Consortium (IPDGC) Correspondence 15 June 2020 Pages: 401 - 402
Reply: ATP10B and the risk for Parkinson’s disease Stefanie SmoldersChristine Van Broeckhoven Correspondence 15 June 2020 Pages: 403 - 404
CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort Stephanie T. JüngerFelipe AndreiuoloTorsten Pietsch Correspondence Open access 08 June 2020 Pages: 405 - 407
CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas Philipp SieversThomas HielscherFelix Sahm Correspondence Open access 08 July 2020 Pages: 409 - 413
Correction to: Somatic mutations in neurons during aging and neurodegeneration Bert M. VerheijenMarc VermulstFred W. van Leeuwen Correction Open access 06 July 2020 Pages: 415 - 415